| Bioactivity | FAAH/MAGL-IN-4 (Compound 13) is a potent fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) inhibitor with IC50s of 9.1 nM and 7.9 μM, respectively. FAAH/MAGL-IN-4 can be used for the research of pain and CNS disorders[1]. |
| Target | IC50: 9.1 nM (FAAH), 7.9 μM (MAGL) |
| Name | FAAH/MAGL-IN-4 |
| CAS | 256383-45-6 |
| Formula | C15H25BO2 |
| Molar Mass | 248.17 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Anna Minkkilä, et al. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60. |
FAAH/MAGL-IN-4
CAS: 256383-45-6 F: C15H25BO2 W: 248.17
FAAH/MAGL-IN-4 (Compound 13) is a potent fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) inhibitor with
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.